· 6 min de lecture · Dr. Handsun Xiao, MD, CCFP

The Connection Between Blood Sugar and Hormones Your Doctor Isn't Making

The Connection Between Blood Sugar and Hormones Your Doctor Isn’t Making

In conventional medicine, glucose metabolism and hormone health are treated as separate departments. Your endocrinologist manages your thyroid. Your urologist checks your testosterone. Your gynecologist prescribes estrogen. Your family doctor monitors your fasting glucose.

The body does not recognize these departmental boundaries. Glucose regulation and hormonal function are interconnected at every level, from the hypothalamus to the liver to the individual cell. Dysregulation in one system drives dysfunction in the other, and treating either in isolation produces incomplete results. This is why metabolic health must be assessed alongside hormonal function.

How Blood Sugar Disrupts Testosterone

Insulin resistance suppresses the hypothalamic-pituitary-gonadal axis. Elevated circulating insulin reduces GnRH pulse frequency from the hypothalamus, which diminishes LH output from the pituitary, which reduces testosterone production in the testes.

This mechanism operates continuously. A man with undiagnosed insulin resistance is losing testosterone production capacity every day, not because his testes are failing but because the metabolic environment is suppressing the signal to produce.

Simultaneously, insulin resistance promotes visceral fat accumulation, which increases aromatase activity and accelerates the conversion of testosterone to estradiol. The man loses testosterone on two fronts: reduced production and increased conversion.

The European Male Ageing Study, which followed over 3,000 men across eight European countries, found that obesity and metabolic health were stronger predictors of testosterone decline than age itself. Men who maintained metabolic health preserved their testosterone levels better than men who developed insulin resistance, regardless of how many birthdays passed.

How Blood Sugar Disrupts Estrogen and Progesterone

In women, insulin resistance disrupts ovarian function through several pathways.

Elevated insulin stimulates the ovarian theca cells to produce excess androgens, a mechanism central to polycystic ovarian syndrome (PCOS). While PCOS is typically diagnosed in younger women, the same insulin-driven androgen excess can persist or emerge in perimenopause, complicating the hormonal transition.

Insulin resistance also impairs follicular development and reduces ovulatory frequency. Fewer ovulations mean less progesterone production, since progesterone is produced primarily by the corpus luteum after ovulation. The result is a state of relative progesterone deficiency that contributes to irregular cycles, heavy bleeding, sleep disruption, and anxiety.

Estrogen metabolism in the liver is influenced by insulin and glucose levels. Elevated insulin increases SHBG suppression in women (as it does in men), altering the ratio of free to bound estrogen and potentially shifting estrogen metabolism toward pathways that are less favourable.

How Blood Sugar Disrupts Thyroid Function

Insulin resistance impairs the conversion of T4 (the inactive thyroid prohormone) to T3 (the biologically active form). The deiodinase enzymes responsible for this conversion are sensitive to metabolic stress, inflammation, and nutrient status, all of which are compromised in the insulin-resistant state.

A woman with insulin resistance may have normal TSH and adequate T4 production but insufficient T3 at the cellular level. Her thyroid gland works. The downstream conversion does not. The result is fatigue, weight gain, cold intolerance, and cognitive slowing that look like hypothyroidism and are, functionally, hypothyroidism.

Elevated insulin also increases reverse T3 production, which occupies T3 receptors without activating them, further reducing the effective thyroid signal at the tissue level.

How Blood Sugar Disrupts Cortisol

Blood sugar instability triggers cortisol release. When glucose drops too quickly (reactive hypoglycemia, common in insulin resistance), the adrenal glands release cortisol to mobilize stored glucose. This is a survival mechanism, but when it occurs repeatedly throughout the day, it produces chronic cortisol elevation.

Chronic cortisol elevation promotes visceral fat storage, breaks down muscle tissue, impairs immune function, disrupts sleep, and further worsens insulin sensitivity. It also suppresses the HPG axis, contributing to reduced testosterone in men and irregular ovarian function in women.

The cycle is self-perpetuating. Blood sugar instability drives cortisol. Cortisol drives insulin resistance. Insulin resistance drives blood sugar instability.

How Hormones Disrupt Blood Sugar

The relationship runs in both directions.

Low testosterone in men directly impairs insulin sensitivity. Testosterone promotes GLUT4 transporter expression in muscle cells, facilitating glucose uptake. When testosterone declines, glucose disposal becomes less efficient, and insulin resistance worsens.

Declining estrogen in women has a similar effect. Estrogen supports insulin sensitivity through direct effects on the insulin signalling cascade and through indirect effects on body composition and inflammation. The menopausal transition is associated with a measurable worsening of insulin sensitivity and an increase in visceral adiposity, independent of age and lifestyle.

Hypothyroidism slows glucose clearance and can produce a pattern of mild hyperinsulinemia even in the absence of dietary excess.

Each hormonal deficiency makes blood sugar regulation harder. Each blood sugar impairment makes hormonal optimization less effective. Treating one without addressing the other leaves half the problem in place.

What a Complete Assessment Captures

A metabolic-hormonal assessment measures both systems simultaneously.

Metabolic markers: Fasting insulin, fasting glucose, HOMA-IR, HbA1c, a complete lipid panel (total cholesterol, LDL, HDL, triglycerides), hs-CRP, and uric acid.

Hormonal markers: Total and free testosterone, SHBG, estradiol, progesterone (timed to cycle in premenopausal women), DHEA-S, a complete thyroid panel (TSH, free T3, free T4, reverse T3), and morning cortisol.

When these panels are reviewed together, patterns emerge that neither panel would reveal alone. A man with a total testosterone of 14 nmol/L, a fasting insulin of 18 µIU/mL, and a free T3 at the bottom of the reference range has a coherent clinical picture that requires a coordinated treatment approach.

Treating the System

The treatment strategy addresses both metabolic and hormonal dysfunction from the outset, recognizing that neither system can be optimized while the other is impaired.

Dietary changes that improve insulin sensitivity (reducing refined carbohydrates, incorporating adequate protein distributed evenly across the day, implementing time-restricted eating) reduce the metabolic pressure on the hormonal axis. The mechanism is direct: lower fasting insulin restores normal signalling through the hypothalamic-pituitary-gonadal axis, normalizing testosterone production in men and restoring ovulatory cycles in women.

Resistance training builds the glucose disposal capacity that both insulin sensitivity and testosterone benefit from. More muscle mass means more glucose uptake per unit of insulin, which lowers fasting insulin. More muscle tissue also produces anabolic signals (myokines) that support hormonal health. And the training stimulus itself—mechanical tension on muscle fibers—is one of the most potent drivers of testosterone production.

Sleep restoration lowers cortisol and improves insulin sensitivity. Poor sleep does not merely fail to recover the body; it actively drives metabolic dysfunction and hormonal suppression. A person who is chronically sleep-deprived is actively fighting against their own physiology.

Hormonal optimization, including testosterone, estradiol, progesterone, and thyroid support as indicated, corrects the hormonal deficits that perpetuate metabolic dysfunction. As testosterone or estrogen levels improve, insulin sensitivity improves through direct effects on glucose transporter expression and indirect effects through changes in body composition. As thyroid function is optimized, metabolic rate normalizes and the body’s capacity for glucose clearance improves.

The combined effect is greater than the sum of its parts. Metabolic and hormonal health are not two separate problems that happen to coexist. They are one interconnected system. Improving one without the other produces partial results and eventual frustration. Treating them together produces durable improvements that compound over time.

Continue Reading

If you found this useful, these related articles may deepen your understanding:


Dr. Handsun Xiao is a McGill trained physician (MD, CCFP) practicing functional medicine and bioidentical hormone therapy in Toronto, with virtual consultations available to patients across Ontario. He holds advanced BHRT certification through WorldLink Medical and IFM AFMCP training. Manus Solis offers physician led BHRT consultations with custom compounding through a dedicated Ontario pharmacy partner. To learn more or book a virtual consultation, visit manussolis.ca.

Commencer

Un échange confidentiel avec notre médecin et fondateur.

Réserver un Appel Découverte